Cargando…
Melatonin Treatment in Kidney Diseases
Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endoc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047594/ https://www.ncbi.nlm.nih.gov/pubmed/36980179 http://dx.doi.org/10.3390/cells12060838 |
_version_ | 1785013964655034368 |
---|---|
author | Markowska, Magdalena Niemczyk, Stanisław Romejko, Katarzyna |
author_facet | Markowska, Magdalena Niemczyk, Stanisław Romejko, Katarzyna |
author_sort | Markowska, Magdalena |
collection | PubMed |
description | Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low. |
format | Online Article Text |
id | pubmed-10047594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100475942023-03-29 Melatonin Treatment in Kidney Diseases Markowska, Magdalena Niemczyk, Stanisław Romejko, Katarzyna Cells Review Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low. MDPI 2023-03-08 /pmc/articles/PMC10047594/ /pubmed/36980179 http://dx.doi.org/10.3390/cells12060838 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Markowska, Magdalena Niemczyk, Stanisław Romejko, Katarzyna Melatonin Treatment in Kidney Diseases |
title | Melatonin Treatment in Kidney Diseases |
title_full | Melatonin Treatment in Kidney Diseases |
title_fullStr | Melatonin Treatment in Kidney Diseases |
title_full_unstemmed | Melatonin Treatment in Kidney Diseases |
title_short | Melatonin Treatment in Kidney Diseases |
title_sort | melatonin treatment in kidney diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047594/ https://www.ncbi.nlm.nih.gov/pubmed/36980179 http://dx.doi.org/10.3390/cells12060838 |
work_keys_str_mv | AT markowskamagdalena melatonintreatmentinkidneydiseases AT niemczykstanisław melatonintreatmentinkidneydiseases AT romejkokatarzyna melatonintreatmentinkidneydiseases |